Sign In
Last checked at 
18 Nov 2009 16:29
ο»Ώ
Annex DTR3
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital letters
|
Name of the Issuer: Hikma Pharmaceuticals PLC |
State whether the notification relates to (i) a transaction notified in accordance withΒ DTRΒ 3.1.2 R, (ii) a disclosure made in accordance with LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006): DTR 3.1.2 R |
||
|
Name of person discharging managerial responsibilities/director: Samih Darwazah, Said Darwazah,Β Mazen Darwazah and Ali Al-Husry |
State whether notification relates to a person connected with a person discharging managerial responsibilities/Β director named in 3 and identify the connected person: Yes: Darhold Limited |
||
|
Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficialΒ interest: Beneficial interest Darhold Limited |
Description of shares (including class), debentures or derivatives or financial instruments relating to shares: Ordinary Shares |
||
|
Name of registered shareholders(s) and, if more than one, the number of shares held by each of them: PNBΒ Paribas Securities Services account for andΒ on behalf of CSFB |
State the nature of the transaction: The transaction comprises aΒ capΒ andΒ floorΒ transaction involving A variable forward sale of up to 3,000,000 Ordinary Shares A stock loan of up to 3,000,000 Ordinary Shares A pledge over 3,500,000 Ordinary SharesΒ in support of a loan |
||
|
Number of shares, debentures or financial instruments relating to shares acquired: None |
Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage): N/A |
||
|
Number of shares, debentures or financial instruments relating to shares disposed: Up to 3,000,000Β ordinary shares mayΒ be disposed ofΒ pursuant to the variable forward saleΒ andΒ Darhold Limited may elect inΒ its sole discretion to settle the variable forward sale in cashΒ instead of shares |
Percentage of issued class disposed (treasury shares of that class should not be taken into account whenΒ calculating percentage): The variable forward sale and stockΒ loan relates toΒ up toΒ approximatelyΒ 1.58 per cent. of all ordinary shares The share pledge relates to approximatelyΒ 1.84 per cent. of all ordinary shares.Β In connection with this transaction a corresponding number of ordinary shares have been released from pre-existing pledges. |
||
|
Price per share or value of transaction: The variable forward sale price will be determined by the market price at the time of settlement,Β subject to: A minimumΒ (floor)Β priceΒ ofΒ 421Β pence per ordinary share; and A maximumΒ (cap)Β price. ofΒ 561Β pence per ordinary share. |
Date and place of transaction: Documents executed onΒ 14 OctoberΒ 2009Β and pricing finalised on 13 November 2009, London |
||
|
Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage): 57,183,028Β -Β 29.9Β per cent. |
Date issuer informed of transaction: 16 November 2009 |
|
If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes |
|||
|
Date of grant |
Period during which or date on which exercisable |
||
|
Total amount paid (if any) for grant of the option |
Description of shares or debentures involved (class and number) |
||
|
Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise |
Total number of shares or debentures over which options held following notification |
||
|
Any additional information |
Name of contact and telephone number for queries |
||
|
Name of authorised official or issuer responsible for making notification |
|
Date of notificationΒ 18 November 2009 |
Notes:
This form is intended for use by anΒ issuerΒ to make aΒ RISΒ notification required byΒ DTR 3.1.4
(1) AnΒ issuerΒ making a notification in respect of a transaction relating to the shares or debentures of theΒ issuerΒ should complete boxes 1 to 16, 23 and 24.
(2) AnΒ issuerΒ making a notification in respect of a derivative relating the shares of theΒ issuerΒ should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) AnΒ issuerΒ making a notification in respect of options granted to aΒ director/person discharging managerial responsibilitiesΒ should complete boxes 1 to 3 and 17 to 24.
(4) AnΒ issuerΒ making a notification in respect of aΒ financial instrumentΒ relating to the shares of theΒ issuerΒ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Follow the stocks
